About the Authors
- Alessandro Armuzzi
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation IBD Unit, Presidio Columbus Fondazione Policlinico A. Gemelli IRCCS–Università Cattolica del Sacro Cuore, Rome, Italy
- Marco daCosta DiBonaventura
-
Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing
* E-mail: Marco.DiBonaventura@pfizer.com
Affiliation Patient Health Impact, Pfizer Inc, New York, NY, United States of America
- Miriam Tarallo
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Patient Health Impact, Pfizer Inc, Rome, Italy
- James Lucas
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Adelphi Real World, Macclesfield, SK, United Kingdom
- Daniel Bluff
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Adelphi Real World, Macclesfield, SK, United Kingdom
- Benjamin Hoskin
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Adelphi Real World, Macclesfield, SK, United Kingdom
- Danielle Bargo
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Patient Health Impact, Pfizer Inc, New York, NY, United States of America
- Joseph C. Cappelleri
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Biostatistics, Pfizer Inc, Groton, CT, United States of America
- Daniel Quirk
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Medical Affairs, Pfizer Inc, Collegeville, PA, United States of America
- Leonardo Salese
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Medical Affairs, Pfizer Inc, Collegeville, PA, United States of America
Competing Interests
We have the following interests: This study was funded by Pfizer Inc and was conducted by Adelphi Real World. AA has been involved in advisory boards for, and received research support from, Pfizer Inc, and has received research support from MSD and Takeda, lecture fees from AbbVie, Amgen, AstraZeneca, Chiesi, Ferring, Hospira, Janssen, Medtronic, Mitsubishi-Tanabe, MSD, Mundipharma, Nikkiso, Otsuka, Pfizer Inc, Takeda, TiGenix, Zambon, and consultancy fees from AbbVie, Allergan, Amgen, Biogen Idec, Bristol-Myers Squibb, Celgene, Celltrion, Eli Lilly, Ferring, Hospira, Janssen, MSD, Mundipharma, Mylan, Pfizer Inc, Samsung Bioepis, Sandoz, Sofar, and Takeda. JL, DBl, and BH acted as consultants for Pfizer Inc. MD, MT, JC, DQ, and LS are employees and stockholders of Pfizer Inc. DBa, was an employee of Pfizer at the time of the study and during manuscript development. JL, DBl and BH are employed by Adelphi Real World. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.